Montgomery VA - Search Results

1

Smith LA, Jensen MJ, Montgomery VA, Brown DR, Ahmed SA, Smith TJ. Smith LA, et al. Among authors: montgomery va. Mov Disord. 2004 Mar;19 Suppl 8:S48-52. doi: 10.1002/mds.20009. Mov Disord. 2004. PMID: 15027054

2

Protection with recombinant Clostridium botulinum C1 and D binding domain subunit (Hc) vaccines against C and D neurotoxins.

Webb RP, Smith TJ, Wright PM, Montgomery VA, Meagher MM, Smith LA. Webb RP, et al. Among authors: montgomery va. Vaccine. 2007 May 22;25(21):4273-82. doi: 10.1016/j.vaccine.2007.02.081. Epub 2007 Mar 16. Vaccine. 2007. PMID: 17395341

3

Purification, potency, and efficacy of the botulinum neurotoxin type A binding domain from Pichia pastoris as a recombinant vaccine candidate.

Byrne MP, Smith TJ, Montgomery VA, Smith LA. Byrne MP, et al. Among authors: montgomery va. Infect Immun. 1998 Oct;66(10):4817-22. doi: 10.1128/IAI.66.10.4817-4822.1998. Infect Immun. 1998. PMID: 9746584 Free PMC article.

4

Recombinant C fragment of botulinum neurotoxin B serotype (rBoNTB (HC)) immune response and protection in the rhesus monkey.

Boles J, West M, Montgomery V, Tammariello R, Pitt ML, Gibbs P, Smith L, LeClaire RD. Boles J, et al. Toxicon. 2006 Jun 15;47(8):877-84. doi: 10.1016/j.toxicon.2006.02.013. Epub 2006 Mar 24. Toxicon. 2006. PMID: 16730042

5

Diagnostic and possible therapeutic application of a monoclonal antibody (14G8) directed against botulinum type C neurotoxin.

Montgomery VA, Smith LA. Montgomery VA, et al. Hybridoma (Larchmt). 2011 Jun;30(3):209-16. doi: 10.1089/hyb.2010.0109. Hybridoma (Larchmt). 2011. PMID: 21707354

6

Development of an o-pthalaldehyde (OPA) assay to measure protein content in Ricin Vaccine E. coli (RVEc™).

Montgomery VA, Lindsey CY, Smith LA, Webb RP. Montgomery VA, et al. Vaccine. 2021 Jan 15;39(3):564-570. doi: 10.1016/j.vaccine.2020.12.008. Epub 2020 Dec 16. Vaccine. 2021. PMID: 33339670 Free article.

7

Identification and biochemical characterization of small-molecule inhibitors of Clostridium botulinum neurotoxin serotype A.

Roxas-Duncan V, Enyedy I, Montgomery VA, Eccard VS, Carrington MA, Lai H, Gul N, Yang DC, Smith LA. Roxas-Duncan V, et al. Among authors: montgomery va. Antimicrob Agents Chemother. 2009 Aug;53(8):3478-86. doi: 10.1128/AAC.00141-09. Epub 2009 Jun 15. Antimicrob Agents Chemother. 2009. PMID: 19528275 Free PMC article.

8

Ex vivo inhibition of Clostridium botulinum neurotoxin types B, C, E, and F by small molecular weight inhibitors.

Montgomery VA, Ahmed SA, Olson MA, Mizanur RM, Stafford RG, Roxas-Duncan VI, Smith LA. Montgomery VA, et al. Toxicon. 2015 May;98:12-9. doi: 10.1016/j.toxicon.2015.02.012. Epub 2015 Feb 20. Toxicon. 2015. PMID: 25707753

9

A matrix-focused structure-activity and binding site flexibility study of quinolinol inhibitors of botulinum neurotoxin serotype A.

Harrell WA Jr, Vieira RC, Ensel SM, Montgomery V, Guernieri R, Eccard VS, Campbell Y, Roxas-Duncan V, Cardellina JH 2nd, Webb RP, Smith LA. Harrell WA Jr, et al. Bioorg Med Chem Lett. 2017 Feb 1;27(3):675-678. doi: 10.1016/j.bmcl.2016.11.019. Epub 2016 Nov 9. Bioorg Med Chem Lett. 2017. PMID: 28043798

10

Potent neutralization of botulinum neurotoxin by recombinant oligoclonal antibody.

Nowakowski A, Wang C, Powers DB, Amersdorfer P, Smith TJ, Montgomery VA, Sheridan R, Blake R, Smith LA, Marks JD. Nowakowski A, et al. Among authors: montgomery va. Proc Natl Acad Sci U S A. 2002 Aug 20;99(17):11346-50. doi: 10.1073/pnas.172229899. Epub 2002 Aug 12. Proc Natl Acad Sci U S A. 2002. PMID: 12177434 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

17 results

Search Page